Characteristics and outcomes of lung cancer patients presenting through the emergency department: a Waikato District Health Board study.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
27 Sep 2024
Historique:
medline: 26 9 2024
pubmed: 26 9 2024
entrez: 26 9 2024
Statut: epublish

Résumé

This research examines the characteristics and survival outcomes of patients receiving a lung cancer diagnosis after attending the emergency department (ED) of Waikato hospitals in New Zealand. This retrospective study was based on a comprehensive database of Waikato patients recorded on the Midland Lung Cancer Register from 2011 to 2021. We compared the characteristics of patients with and without emergency presentations within 14 days before their lung cancer diagnosis. The survival of patients with and without ED attendance was compared between Māori and non-Māori. This study also analysed the odds ratios (OR) of presenting via ED before diagnosis and surviving 12 months based on logistic regressions. In total, 2,397 patients were included, with 39.6% attending the ED prior to diagnosis. Māori were 1.27 times more likely than non-Māori to be diagnosed after attending the ED. Other characteristics of patients included being male, being diagnosed with small cell lung cancer and having more advanced-stage disease. Patients attending the ED were less likely to survive 12 months than those without ED visits (OR 0.42), and those with two or more ED visits were even less likely to survive 12 months (OR 0.33). Patients presenting through the ED have more advanced-stage disease, while those presenting through their general practitioners (GPs) have evidence of being diagnosed earlier and having better survival. Barriers to early diagnoses through attendance with a GP, particularly for Māori and for men, need to be explored.

Identifiants

pubmed: 39326018
doi: 10.26635/6965.6481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-24

Subventions

Organisme : Health Research Council of New Zealand
ID : This work was supported by the Health Research Council of New Zealand (HRC ref ID: 21/990).

Informations de copyright

© PMA.

Déclaration de conflit d'intérêts

All authors disclose no competing interests.

Auteurs

Ross Lawrenson (R)

Medical Research Centre, University of Waikato, Hamilton, New Zealand.

Chunhuan Lao (C)

Medical Research Centre, University of Waikato, Hamilton, New Zealand.

Ha Nguyen (H)

Research and Communications, Breast Cancer Foundation NZ, Auckland, New Zealand.

Lucia Moosa (L)

Cancer and Chronic Conditions Directorate, Health New Zealand - Te Whatu Ora Waikato, Hamilton, New Zealand.

Rawiri Keenan (R)

Medical Research Centre, University of Waikato, Hamilton, New Zealand.

George Laking (G)

Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand.

Janice Wong (J)

Research and Communications, Breast Cancer Foundation NZ, Auckland, New Zealand.

Mark Elwood (M)

Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH